Optimize Patient Care with Precision Medicine
Our Expedio™ Hereditary Cancer and Inspexion™ Pharmacogenomics tests are physician-directed genetic screenings that offer a cost-effective strategy designed to achieve optimized, personalized care for your patients.
Kailos Genetics precision medicine tests utilize next generation DNA sequencing to customize healthcare for all patients. Personalize patient care and treatment while saving healthcare dollars. Contact us to discover what Kailos Genetics can do for your organization.
Please click here to see the poster "Pharmacogenomics Applied to Chronic Pain Treatment in Primary Care (PGx-ACT) trial: A Largely Virtual Randomized Trial" presented by Dr. Max Smith from MedStar Health at the 2023 American Society of Human Genetics Annual Meeting which utilized the Kailos Genetics pharmacogenomics sequencing test. The primary objective of the study was to identify the effects of providing pharmacogenomic results and recommendations for patients with chronic pain who are treated in primary care clinics vs. standard care.
Our CLIA-certified laboratory uses next generation DNA sequencing to provide the most complete, accurate and transparent genetic variation information, delivered in your preferred format for easy integration into your health information system.
Our CLIA-certified laboratory uses next generation DNA sequencing to provide the most complete, accurate and transparent pharmacogenetics information, delivered in your preferred format for easy integration into your health information system.
We offer a complete sequencing solution that includes every reagent or service your research laboratory requires, from assay design to data analysis and everything in between.
Get In Touch
601 Genome Way
Suite 2005
Huntsville, AL 35806
+1-866-833-6865
9am - 5pm (Central Time)
For general inquires support@kailosgenetics.com